Paclitaxel With Pertuzumab Plus Trastuzumab in Metastatic Breast Cancer
Автор: OncLive
Загружено: 2013-08-28
Просмотров: 2216
The FDA approved pertuzumab in June 2012 to be used in combination with trastuzumab and docetaxel for untreated patients with HER2-positive metastatic breast cancer. In this segment, panelists discuss utilizing pertuzumab with trastuzumab and paclitaxel, rather than docetaxel.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/...
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: